FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshio Hayashi

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Physiology

Gene Expression

Co-author Network

Publications

TOP 3
Ritsuko Oura; Eiji Tanaka; Akiko Yamada; Rieko Arakaki; Yoshio Hayashi; Yasusei Kudo; Naozumi Ishimaru
Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.
Takashi Izawa; Tomoyuki Kondo; Yasusei Kudo; Mie Kurosawa; Kazuma Matsumoto; Ritsuko Oura; Eiji Tanaka; Akiko Yamada; Rieko Arakaki; Yoshio Hayashi; Naozumi Ishimaru
Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
Yoshio Hayashi; Rieko Arakaki; Naozumi Ishimaru
[II. Autoimmune disease: 5. Sjögren's syndrome].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshio Hayashi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ritsuko Oura; Eiji Tanaka; Akiko Yamada; Rieko Arakaki; Yoshio Hayashi; Yasusei Kudo; Naozumi Ishimaru
Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(2):578-85.
2012: Takashi Izawa; Tomoyuki Kondo; Yasusei Kudo; Mie Kurosawa; Kazuma Matsumoto; Ritsuko Oura; Eiji Tanaka; Akiko Yamada; Rieko Arakaki; Yoshio Hayashi; Naozumi Ishimaru
Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
PloS one 2012;7(12):e48798.
2011: Yoshio Hayashi; Rieko Arakaki; Naozumi Ishimaru
[II. Autoimmune disease: 5. Sjögren's syndrome].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2011;100(5):1262-8.
2011: Yu Lei; Adiratna Mat Ripen; Naozumi Ishimaru; Izumi Ohigashi; Takashi Nagasawa; Lukas T Jeker; Michael R Bösl; Georg A Holländer; Yoshio Hayashi; Rene de Waal Malefyt; Takeshi Nitta; Yousuke Takahama
Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development.
The Journal of experimental medicine 2011;208(2):383-94.
2011: Megumi Watanabe; Naozumi Ishimaru; Meinar Nur Ashrin; Rieko Arakaki; Akiko Yamada; Tetsuo Ichikawa; Yoshio Hayashi
A novel DC therapy with manipulation of MKK6 gene on nickel allergy in mice.
PloS one 2011;6(4):e19017.
2011: Emi Kawakami; Nao Kinouchi; Taro Adachi; Yutaka Ohsawa; Naozumi Ishimaru; Hideyo Ohuchi; Yoshihide Sunada; Yoshio Hayashi; Eiji Tanaka; Sumihare Noji
Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice.
Development, growth & differentiation 2011;53(1):48-54.
2010: Rieko Arakaki; Naozumi Ishimaru; Yoshio Hayashi
Immunotherapeutic targets in estrogen deficiency-dependent Sjögren's syndrome-related manifestations.
Immunotherapy 2010;2(3):339-46.
2010: Takashi Sakai; Li Liu; Xichuan Teng; Naozumi Ishimaru; Rika Mukai-Sakai; Nam Hoang Tran; Sun Mi Kim; Nobuya Sano; Yoshio Hayashi; Ryuji Kaji; Kiyoshi Fukui
Inflammatory disease and cancer with a decrease in Kupffer cell numbers in Nucling-knockout mice.
International journal of cancer. Journal international du cancer 2010;126(5):1079-94.
2010: Akiko Yamada; Naozumi Ishimaru; Rieko Arakaki; Nobuhiko Katunuma; Yoshio Hayashi
Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity.
PloS one 2010;5(9):e12894.
2010: Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.
PloS one 2010;5(1):e8588.
2009: Takeo Iwata; Masamichi Kuwajima; Akiko Sukeno; Naozumi Ishimaru; Yoshio Hayashi; Martin Wabitsch; Noriko Mizusawa; Mitsuo Itakura; Katsuhiko Yoshimoto
YKL-40 secreted from adipose tissue inhibits degradation of type I collagen.
Biochemical and biophysical research communications 2009;388(3):511-6.
2009: Naozumi Ishimaru; Atsuya Takagi; Masayuki Kohashi; Akiko Yamada; Rieko Arakaki; Jun Kanno; Yoshio Hayashi
Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(10):6576-86.
2009: Rieko Arakaki; Ai Nagaoka; Naozumi Ishimaru; Akiko Yamada; Satoko Yoshida; Yoshio Hayashi
Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background.
The American journal of pathology 2009;174(5):1715-24.
2009: Yoshio Hayashi; Rieko Arakaki; Naozumi Ishimaru
Salivary gland and autoimmunity.
The journal of medical investigation : JMI 2009;56 Suppl():185-91.
2008: Naozumi Ishimaru; Rieko Arakaki; Satoko Yoshida; Akiko Yamada; Sumihare Noji; Yoshio Hayashi
Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy.
The Journal of experimental medicine 2008;205(12):2915-27.
2008: Yu Hikosaka; Takeshi Nitta; Izumi Ohigashi; Kouta Yano; Naozumi Ishimaru; Yoshio Hayashi; Mitsuru Matsumoto; Koichi Matsuo; Josef M Penninger; Hiroshi Takayanagi; Yoshifumi Yokota; Hisakata Yamada; Yasunobu Yoshikai; Jun-Ichiro Inoue; Taishin Akiyama; Yousuke Takahama
The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.
Immunity 2008;29(3):438-50.
2008: Naozumi Ishimaru; Akiko Yamada; Masayuki Kohashi; Rieko Arakaki; Tetsuyuki Takahashi; Keisuke Izumi; Yoshio Hayashi
Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(10):6997-7008.
2008: Masayuki Kohashi; Naozumi Ishimaru; Rieko Arakaki; Yoshio Hayashi
Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome.
Arthritis and rheumatism 2008;58(2):389-400.
2007: Kazuhito Satomura; Reiko Tokuyama; Yasuhumi Yamasaki; Tetsuya Yuasa; Seiko Tatehara; Naozumi Ishimaru; Yoshio Hayashi; Masaru Nagayama
Possible involvement of stem cell factor and endothelin-1 in the emergence of pigmented squamous cell carcinoma in oral mucosa.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2007;36(10):621-4.
2007: Naoko Ohtani; Yuko Imamura; Kimi Yamakoshi; Fumiko Hirota; Rika Nakayama; Yoshiaki Kubo; Naozumi Ishimaru; Akiko Takahashi; Atsushi Hirao; Takatsune Shimizu; David J Mann; Hideyuki Saya; Yoshio Hayashi; Seiji Arase; Mitsuru Matsumoto; Nakao Kazuki; Eiji Hara
Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(38):15034-9.
2007: Takashi Izawa; Naozumi Ishimaru; Keiji Moriyama; Masayuki Kohashi; Rieko Arakaki; Yoshio Hayashi
Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.
Blood 2007;110(1):242-50.
2006: Naoto Suzue; Takeshi Nikawa; Yuko Onishi; Chiharu Yamada; Katsuya Hirasaka; Takayuki Ogawa; Harumi Furochi; Hirofumi Kosaka; Kazumi Ishidoh; Hua Gu; Shin'ichi Takeda; Naozumi Ishimaru; Yoshio Hayashi; Hironori Yamamoto; Kyoichi Kishi; Natsuo Yasui
Ubiquitin ligase Cbl-b downregulates bone formation through suppression of IGF-I signaling in osteoblasts during denervation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(5):722-34.
2006: Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.
Molecular and cellular biology 2006;26(8):2924-35.
2006: Hirotsugu Kurobe; Cunlan Liu; Tomoo Ueno; Fumi Saito; Izumi Ohigashi; Natalie Seach; Rieko Arakaki; Yoshio Hayashi; Tetsuya Kitagawa; Martin Lipp; Richard L Boyd; Yousuke Takahama
CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance.
Immunity 2006;24(2):165-77.
2006: Kumi Obara; Fumio Ide; Kenji Mishima; Hiroko Inoue; Hiroyuki Yamada; Yoshio Hayashi; Ichiro Saito
Biological and oncogenic properties of p53-deficient salivary gland epithelial cells with particular emphasis on stromal-epithelial interactions in tumorigenesis.
Pathobiology : journal of immunopathology, molecular and cellular biology 2006;73(5):261-70.
2005: Katsushi Miyazaki; Noriaki Takeda; Naozumi Ishimaru; Fumie Omotehara; Rieko Arakaki; Yoshio Hayashi
Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
The American journal of pathology 2005;167(4):1051-9.
2005: Akiko Yoshida; Ahmad Piroozmand; Akiko Sakurai; Mikako Fujita; Tsuneo Uchiyama; Tooru Kimura; Yoshio Hayashi; Yoshiaki Kiso; Akio Adachi
Establishment of a biological assay system for human retroviral protease activity.
Microbes and infection / Institut Pasteur 2005;7(5-6):820-4.
2005: Noriyuki Kuroda; Tasuku Mitani; Naoki Takeda; Naozumi Ishimaru; Rieko Arakaki; Yoshio Hayashi; Yoshimi Bando; Keisuke Izumi; Takeshi Takahashi; Takashi Nomura; Shimon Sakaguchi; Tomoo Ueno; Yousuke Takahama; Daisuke Uchida; Shijie Sun; Fumiko Kajiura; Yasuhiro Mouri; Hongwei Han; Akemi Matsushima; Gen Yamada; Mitsuru Matsumoto
Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):1862-70.
2004: Masaru Kobayashi; Natsuo Yasui; Naozumi Ishimaru; Rieko Arakaki; Yoshio Hayashi
Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Arthritis and rheumatism 2004;50(12):3974-84.
2004: Yuki Hayashi; Naozumi Ishimaru; Rieko Arakaki; Shin-ichi Tsukumo; Hitomi Fukui; Kenji Kishihara; Hiroshi Shiota; Koji Yasutomo; Yoshio Hayashi
Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
Arthritis and rheumatism 2004;50(9):2903-10.
2004: Yoshio Hayashi; Rieko Arakaki; Naozumi Ishimaru
Apoptosis and estrogen deficiency in primary Sjögren syndrome.
Current opinion in rheumatology 2004;16(5):522-6.
2004: Tomoko Yoneda; Naozumi Ishimaru; Rieko Arakaki; Masaru Kobayashi; Takashi Izawa; Keiji Moriyama; Yoshio Hayashi
Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis.
Endocrinology 2004;145(5):2384-91.
2004: Hideko Endo; Mitsuyoshi Hirokawa; Naozumi Ishimaru; Yasushi Tanaka; Michiko Yamashita; Mika Sakaki; Yoshio Hayashi; Toshiaki Sano
Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
Pathology international 2004;54(3):145-50.
2004: Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
Immunology 2004;111(2):223-9.
2003: Kouichi Ogawa; Shinji Nagahiro; Rieko Arakaki; Naozumi Ishimaru; Masaru Kobayashi; Yoshio Hayashi
Anti-alpha-fodrin autoantibodies in Moyamoya disease.
Stroke; a journal of cerebral circulation 2003;34(12):e244-6.
2003: Naozumi Ishimaru; Rieko Arakaki; Megumi Watanabe; Masaru Kobayashi; Katsushi Miyazaki; Yoshio Hayashi
Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.
The American journal of pathology 2003;163(4):1481-90.
2003: Yoshio Hayashi; Rieko Arakaki; Naozumi Ishimaru
The role of caspase cascade on the development of primary Sjögren's syndrome.
The journal of medical investigation : JMI 2003;50(1-2):32-8.
2002: Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
The Journal of clinical investigation 2002;110(3):361-9.
2002: Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Kenji Mishima; Rieko Arakaki; Takashi Suda; Ichiro Saito; Yoshio Hayashi
Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(2):1050-7.
2002: Kenji Mishima; Kazuya Inoue; Yoshio Hayashi
Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma.
Oral oncology 2002;38(5):468-74.
2001: Naozumi Ishimaru; Kumiko Yanagi; K Ogawa; Takashi Suda; Ichiro Saito; Yoshio Hayashi
Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(10):6031-7.
2001: Hiroko Inoue; K Tsubota; M Ono; Yasuhiro Kizu; Fumio Mizuno; K Takada; Koichi Yamada; Kumiko Yanagi; Yoshio Hayashi; Ichiro Saito
Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(9):5801-9.
2000: Kaoru Saegusa; Naozumi Ishimaru; N Haneji; Kumiko Yanagi; T Yoneda; Ichiro Saito; Yoshio Hayashi
Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.
Scandinavian journal of immunology 2000;52(3):264-70.
2000: Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; N Haneji; M Nishino; M Azuma; Ichiro Saito; Yoshio Hayashi
Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(4):2251-7.
2000: Naozumi Ishimaru; T Yoneda; Kaoru Saegusa; Kumiko Yanagi; N Haneji; K Moriyama; Ichiro Saito; Yoshio Hayashi
Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
The American journal of pathology 2000;156(5):1557-64.
2000: Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; N Haneji; M Nishino; M Azuma; Ichiro Saito; Yoshio Hayashi
Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
Clinical and experimental immunology 2000;119(2):354-60.
2000: Yoshio Hayashi; K Yayagi; N Haneji
Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Archivum immunologiae et therapiae experimentalis 2000;48(5):399-403.
1999: M Horiuchi; S Yamano; Hiroko Inoue; J Ishii; Yoshifumi Nagata; H Adachi; M Ono; J N Renard; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome.
Journal of clinical pathology 1999;52(11):833-7.
1999: Naozumi Ishimaru; Kaoru Saegusa; Kumiko Yanagi; N Haneji; Ichiro Saito; Yoshio Hayashi
Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.
The American journal of pathology 1999;155(1):173-81.
1999: M Takahashi; Naozumi Ishimaru; Kumiko Yanagi; Kaoru Saegusa; N Haneji; Hiroshi Shiota; Yoshio Hayashi
Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.
Clinical and experimental immunology 1999;116(2):231-7.
1999: Ichiro Saito; K Haruta; M Shimuta; Hiroko Inoue; H Sakurai; Koichi Yamada; Naozumi Ishimaru; H Higashiyama; T Sumida; H Ishida; Takashi Suda; T Noda; Yoshio Hayashi; K Tsubota
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(5):2488-94.
1998: Kumiko Yanagi; Naozumi Ishimaru; N Haneji; Kaoru Saegusa; Ichiro Saito; Yoshio Hayashi
Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
European journal of immunology 1998;28(10):3336-45.
1998: Yoshio Hayashi
[Identification of organ-specific autoantigen in Sjögren's syndrome].
Seikagaku. The Journal of Japanese Biochemical Society 1998;70(5):381-5.
1997: Kumiko Yanagi; N Haneji; Naozumi Ishimaru; Ichiro Saito; Yoshio Hayashi
Analysis of T cell receptor Vbeta usage in the autoimmune sialadenitis of non-obese diabetic (NOD) mice.
Clinical and experimental immunology 1997;110(3):440-6.
1997: M Takahashi; Naozumi Ishimaru; Kumiko Yanagi; N Haneji; Ichiro Saito; Yoshio Hayashi
High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
Clinical and experimental immunology 1997;109(3):555-61.
1997: N Haneji; T Nakamura; K Takio; Kumiko Yanagi; H Higashiyama; Ichiro Saito; S Noji; H Sugino; Yoshio Hayashi
Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Science (New York, N.Y.) 1997;276(5312):604-7.
1997: Naozumi Ishimaru; N Haneji; H Hamano; Y Kumiko; M Takahashi; Yoshio Hayashi
Accelerated onset of age-related autoimmune lesions in MRL/+ mice by ovariectomy.
Mechanisms of ageing and development 1997;93(1-3):145-56.
1996: Yoshio Hayashi; N Haneji; H Hamano; Kumiko Yanagi; M Takahashi; Naozumi Ishimaru
Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Cellular immunology 1996;171(2):217-25.
1996: M Takahashi; Y Mimura; H Hamano; N Haneji; Kumiko Yanagi; Yoshio Hayashi
Mechanism of the development of autoimmune dacryodenitis in the mouse model for primary Sjögren's syndrome.
Cellular immunology 1996;170(1):54-62.
1996: Kumiko Yanagi; N Haneji; H Hamano; M Takahashi; H Higashiyama; Yoshio Hayashi
In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Cellular immunology 1996;168(2):243-50.
1996: M Takahashi; Y Mimura; Yoshio Hayashi
Role of the ICAM-1/LFA-1 pathway during the development of autoimmune dacryoadenitis in an animal model for Sjögren's syndrome.
Pathobiology : journal of immunopathology, molecular and cellular biology 1996;64(5):269-74.
1996: H Hamano; N Haneji; Kumiko Yanagi; Naozumi Ishimaru; Yoshio Hayashi
Expression of HLA-DR and cytokine genes on interferon-gamma-stimulated human salivary gland cell line.
Pathobiology : journal of immunopathology, molecular and cellular biology 1996;64(5):255-61.
1996: Yoshio Hayashi; N Haneji; H Hamano
Cytokine gene expression and autoantibody production in Sjögren's syndrome of MRL/lpr mice.
Autoimmunity 1996;23(4):269-77.
1996: Kumiko Yanagi; N Haneji; Naozumi Ishimaru; H Hamano; Yoshio Hayashi
Immunopathological analysis of mucosal melanocyte distribution in the human lower lip of the elderly.
Pathobiology : journal of immunopathology, molecular and cellular biology 1996;64(3):156-60.
1995: Yoshio Hayashi; N Haneji; Kumiko Yanagi; H Higashiyama; H Yagita; H Hamano
Prevention of adoptive transfer of murine Sjögren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1).
Clinical and experimental immunology 1995;102(2):360-7.
1995: Yoshio Hayashi
[Investigations of various animal models for Sjögren's syndrome].
Nihon rinsho. Japanese journal of clinical medicine 1995;53(10):2383-8.
1995: Yoshio Hayashi; H Hamano; N Haneji; Naozumi Ishimaru; Kumiko Yanagi
Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
Arthritis and rheumatism 1995;38(8):1077-84.
1994: Yoshio Hayashi; N Haneji; H Hamano; Kumiko Yanagi
Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
European journal of immunology 1994;24(11):2826-31.
1994: N Haneji; H Hamano; Kumiko Yanagi; Yoshio Hayashi
A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2769-77.
1994: Yoshio Hayashi; N Haneji; H Hamano
Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Pathology international 1994;44(8):559-68.
1993: H Hamano; Ichiro Saito; N Haneji; Y Mitsuhashi; N Miyasaka; Yoshio Hayashi
Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice.
European journal of immunology 1993;23(10):2387-91.
1993: H Deguchi; H Hamano; Yoshio Hayashi
c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.
Acta pathologica japonica 1993;43(7-8):413-22.
1993: H Deguchi; H Hamano; N Haneji; M Takahashi; Yoshio Hayashi
Immunopathology of phenotypic change on human parotid gland adenocarcinoma.
Pathobiology : journal of immunopathology, molecular and cellular biology 1993;61(2):83-8.
1990: A Nakahata; H Deguchi; T Yanagawa; H Yoshida; M Sato; Yoshio Hayashi
Coexpression of intermediate-sized filaments in sialadenoma papilliferum and other salivary gland neoplasms.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1990;19(7):313-8.
1990: Yoshio Hayashi; H Deguchi; A Nakahata; C Kurashima; M Utsuyama; K Hirokawa
Autoimmune sialadenitis: possible models for Sjögren's syndrome and a common aging phenomenon.
Autoimmunity 1990;5(3):215-28.
1990: Yoshio Hayashi; T Takemura; T Akashi; Y Esaki; C Kurashima; K Hirokawa
Immunopathological analysis of interstitial renal lesions in elderly people.
Pathobiology : journal of immunopathology, molecular and cellular biology 1990;58(4):230-5.
1990: Yoshio Hayashi; H Deguchi; A Nakahata; C Kurashima; K Hirokawa
Immunopathological study of neuropeptide expression in human salivary gland neoplasms.
Pathobiology : journal of immunopathology, molecular and cellular biology 1990;58(4):212-20.